Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

Record sales with more records on the horizon

NEXTDC
3:27pm
February 28, 2024
NXT delivered a good result and reiterated guidance. The share price rallied hard not on a big result beat but as the investment community got excited about how significant the digital demand wave will be over the next decade plus. The tech refresh cycle is turning in NXT’s favour. Those scrambling to adopt cloud (centralised compute) will continue to chase cloud but will now also scramble to adopt AI (decentralised compute). NXT has a foot in both camps and a record pipeline. Cloud and colocation demand remain strong but AI is deeply intertwined with both so the coming AI wave favours NXT unique and value business model. We retain our Add recommendation and lift our target price to $20.

NIM rebases as the loan book rebalances

MoneyMe
3:27pm
February 28, 2024
MoneyMe’s (MME) 1H24 result was largely per expectations as key headline operating metrics were pre-released. Total revenue of A$108m (-~11% on pcp) was achieved on a gross loan book of ~A$1.2bn (flat on the sequential half). The key positive in the result, in our view, was the continued uptick of asset quality of the book, with MME focusing on originating higher credit quality loans in recent periods. Our FY24F-FY26F EBITDA is altered by ~-19%-+6% on adjustments to our book yield estimates as secured assets become a higher proportion of the gross loan book as well as some changes to our operating costs assumptions. Our DCF/PB blended valuation (equal-weighted) and price target is lowered marginally to A$0.23 (from A$0.25) on the above changes and a valuation roll-forward. We maintain our Speculative Buy recommendation.

Good start to the year but still plenty to do

Adrad Holdings
3:27pm
February 28, 2024
AHL’s 1H24 revenue and pro forma EBITDA was in line with expectations but underlying NPAT was weaker due to higher D&A. Both segments delivered solid revenue growth with Distribution (formerly Aftermarket) up 7% and Heat Transfer Solutions (HTS) rising 8%. Key positives: Balance sheet remains healthy with net cash (ex-leases) of $15.6m; Group pro forma EBITDA margin increased 20bp to 13.5%; Operating cash flow jumped to $11.1m (vs $3.8m in the pcp) due to improved inventory management. Key negative: HTS earnings and margins were impacted by warranty issues. Management has maintained FY24 guidance for revenue and pro forma EBITDA growth of between 5-8%. Our target price decreases to $1.30 (from $1.40) and we maintain our Add rating. We expect benefits from investments in facilities, staff and rationalisation of the manufacturing footprint to deliver benefits over the long term. Trading on 8.7x FY25F PE and 4.0% yield with a strong balance sheet, we think the stock remains an attractive long-term investment opportunity.

Lower earnings base, with lower risk

Earlypay
3:27pm
February 28, 2024
EPY reported Underlying NPAT of A$2.2m and pro-forma NPAT of A$2.9m. FY24 guidance is >A$4.8m pro-forma (implied 2H24 >A$1.9m). Recent mgmt focus has been on improving risk controls and the funding structure. The recent warehouse refinance removes operational complexity and improves the cost of funds (~1%) and capital efficiency (~A$10m of capital released). Funds-in-use has lowered through 1H24, with mgmt removing areas of client risk and taking a cautious volume approach (SME credit environment weakening). We expect this leads to lower 2H24 earnings but also a lower-risk earnings base. Dividends are expected to resume in 2H24. A buy-back and/or acquisitions will also be considered. Medium term, corporate appeal exists (COGs at ~19.5% of shares). Whilst earnings have re-based and the return to growth has pushed out, EPY’s quality of earnings and balance sheet position has strengthened. The group now needs to prove that sustainable volume and earnings growth can be delivered. We have an Add recommendation but note EPY should be considered higher risk.

National launch imminent for key product

Microba Life Sciences
3:27pm
February 28, 2024
MAP released its 1H results which are tracking in-line with our expectations. The imminent national launch of the MetaPanel test through Sonic Healthcare remains a key focus. We anticipate this increased awareness to spark greater interest in microbiome-related services and products underlining the growing acknowledgment of its impact on overall health across diverse medical fields. We continue to see significant upside here as the testing and services deliver scale, and the therapeutics continues to de-risk. Speculative Buy maintained.

Detecting first Argus sales

Micro-X
3:27pm
February 28, 2024
Apart from the R&D incentive not being recognised as a receivable and the timing of project income, the 1H24 result was broadly in line with expectations. Argus sales remain the key focus and near-term catalyst. We have adjusted R&D forecasts resulting in a lower target price of A$0.25. Speculative Buy maintained.

FDA submission in sight; remains well-funded

EBR Systems
3:27pm
February 28, 2024
CY22 results were broadly in line, with opex up modestly and higher interest expense. The final Premarket Approval (PMA) module remains on track, with management confident in achieving FDA filing in 3QCY24 and approval in 1QCY25. We have made no changes to our estimates or A$1. target price. Speculative Buy recommendation maintained.

This too shall pass

Silk Logistics Holdings
3:27pm
February 28, 2024
SLH delivered what is in our view a resilient 1H24 result in light of ongoing softness in trading conditions, recent port disruptions and a deeper-than-expected pullback in customer inventories. Group Underlying EBITDA of $47.7m (+8% YoY) was 3% ahead of MorgF, whilst Underlying NPAT was -6% below our forecasts. SLH’s FY24 EBIT guidance range of $34-37m implies a largely flat 2H24. Our EBIT forecasts are reduced by -14%/-8%/-4%, driving a revised price target of $2.65ps (from $3.00) and we retain our ADD rating.

A compositional weaker result

NIB Holdings
3:27pm
February 27, 2024
NHF’s 1H24 underlying operating profit (A$144m) was +13% above consensus, but was a low quality beat driven by a Covid-19 provision release in the Australia Residents Health insurance business (ARHI). Excluding this release, the result was a bit softer than expected, particularly in the adjacent businesses (IIHI, NZ, Travel) which all came in below consensus. We lower NHF FY24F/FY25F NPAT forecasts by ~-3% on slightly softer earnings estimates in all key divisions. Our target price is set at A$8.00 (previously A$8.47). With upside to our valuation reduced, we move NHF back to our a Hold call.

Turning the ship

Cooper Energy
3:27pm
February 27, 2024
The real highlight in the 1H24 result was the progress reported at Orbost. With COE flagging continued results from debottlenecking would mitigate the need for a third absorber (which would save ~A$40m capex and deliver higher production). COE reported an impressive 1H24 result, finishing with an underlying NPAT of A$5.4m (vs Visible Alpha consensus/MorgansF -A$1.0/$4.7m). We maintain an Add rating on COE with an upgraded A$0.28ps Target Price.

News & Insights

Investment Watch is a flagship product that brings together our analysts' view of economic and investment strategy themes, sector outlooks and best stock ideas for our clients.

Investment Watch is a quarterly publication produced by Morgans that delves into key insights for equity and economic strategy. This latest publication will cover;

  • Asset Allocation – not the time to play defence
  • Economic Strategy – averting a world recession
  • Equity Strategy – attention turns to August
  • Resources & Energy – domestic gas coming to the boil
  • Banks – befuddling
  • Updated Morgans Best Ideas

Morgans clients receive exclusive insights such as access to our latest Investment Watch publication. Download the preview now.

      
View Investment Watch
      

Preview

We think the investment landscape remains favourable. The US economic fundamentals are strong with no significant downside risks to growth in the near-term. European leading indicators suggest a turning point is near and China’s cyclical recovery is still gaining momentum after bottoming earlier in the year.

Meanwhile, the Australian economy continues to defy expectations of a sharper slowdown. In our view, this is not the time to play defence and continue to expect growth assets such as equities and property to do well. This quarter, we look at tactical opportunities in private credit, global equities and across the Australian equity market (resources, agriculture, travel and technology).

Read more
Our best ideas are those that we think offer the highest risk-adjusted returns over a 12-month timeframe supported by a higher-than-average level of confidence. They are our most preferred sector exposures.

As interest rates normalise, earnings quality, market positioning and balance sheet strength will play an important role in distinguishing companies from their peers. We think stocks will continue to diverge in performance at the market and sector level, and investors need to take a more active approach than usual to manage portfolios.

Additions: This month we add Elders.

July best ideas

Elders (ELD)

Small cap | Food/Ag

ELD is one of Australia’s leading agribusinesses. It has an iconic brand, 185 years of history and a national distribution network throughout Australia. With the outlook for FY25 looking more positive and many growth projects in place to drive strong earnings growth over the next few years, ELD is a key pick for us. It is also trading on undemanding multiples and offers an attractive dividend yield.

Technology One (TNE)

Small cap | Technology

TNE is an Enterprise Resource Planning (aka Accounting) company. It’s one of the highest quality companies on the ASX with an impressive ROE, nearly $200m of net cash and a 30-year history of growing its earnings by ~15% and its dividend ~10% per annum. As a result of its impeccable track record TNE trades on high PE. With earnings growth looking likely to accelerate towards 20% pa, we think TNE’s trading multiple is likely to expand from here.

ALS Limited

Small cap | Industrials

ALQ is the dominant global leader in geochemistry testing (>50% market share), which is highly cash generative and has little chance of being competed away. Looking forward, ALQ looks poised to benefit from margin recovery in Life Sciences, as well as a cyclical volume recovery in Commodities (exploration). Timing around the latter is less certain, though our analysis suggests this may not be too far away (3-12 months). All the while, gold and copper prices - the key lead indicators for exploration - are gathering pace.

Clearview Wealth

Small cap | Financial Services

CVW is a challenger brand in the Australian retail life insurance market (market size = ~A$10bn of in-force premiums). CVW sees its key points of differentiation as its: 1) reliable/trusted brand; 2) operational excellence (in product development, underwriting and claims management); and 3) diversified distributing network. CVW's significant multiyear Business Transformation Program has, in our view, shown clear signs of driving improved growth and profitability in recent years. We expect further benefits to flow from this program in the near term, and we see CVW's FY26 key business targets as achievable. With a robust balance sheet, and with our expectations for ~21% EPS CAGR over the next three years, we see CVW's current ~11x FY25F PE multiple as undemanding.

GUD Holdings

Large cap | Consumer Discretionary

GUD is a high-quality business with an entrenched market position in its core operations and deep growth opportunities in new markets. We view GUD’s investment case as compelling, a robust earnings base of predominantly non-discretionary products, structural industry tailwinds supporting organic growth and ongoing accretive M&A optionality. We view the ~12x multiple as undemanding given the resilient earnings and long-duration growth outlook for the business ahead.

Stanmore Resources

Small cap | Metals & Mining

SMR’s assets offer long-life cashflow leverage at solid margins to the resilient outlook for steelmaking coal prices. We’re strong believers that physical coal markets will see future cycles of “super-pricing” well above consensus expectations, supporting further periods of elevated cash flows and shareholder returns. We like SMR’s ability to pay sustainable dividends and its inventory of organic growth options into the medium term, with meaningful synergies, and which look under-recognised by the market. We see SMR as the default ASX-listed producer for pure met coal exposure. We maintain an Add and see compelling value with SMR trading at less than 0.8x P/NPV.


Morgans clients receive full access of the Best Ideas, including our large, mid and small-cap key stock picks.

      
Contact us
      
Read more
There are many reasons to invest in equities. Historically, they have offered higher capital returns than many other asset classes. Furthermore, they provide liquidity and diversification and allow investors to participate in the growth of high performing businesses and sectors.

There are many reasons to invest in equities. Historically, they have offered higher capital returns than many other asset classes. Furthermore, they provide liquidity and diversification and allow investors to participate in the growth of high performing businesses and sectors. Not to be overlooked, however, is their capacity to provide an income stream through regular dividends. In the Month Ahead for July, we highlight a selection of Australian equities that offer superior forecast dividend yields and may be suitable investments for those seeking income.

Happy New Financial Year!

BHP Group (BHP)

BHP Group (ASX: BHP) is the largest diversified mining company in the world. BHP has extensive iron ore, copper, nickel and coal operations, and will soon add potash to its portfolio once its massive Jansen project comes online in late 2026. Besides nickel, which has proven volatile, the rest of BHP’s basket of market exposures share the similar characteristic of typically boasting bumper margins throughout the cycle. Over the last decade BHP has shifted its corporate strategy toward streamlining its business, protecting its balance sheet, slowing its pace of investment and maximising shareholder returns. Despite an impressive shareholder performance over recent years, BHP’s dividend yield has remained above market.

      
BHP coverage report
      

Dalrymple Bay Infrastructure (DBI)

Dalrymple Bay Infrastructure (ASX: DBI). DBI owns a fully contracted coal export terminal in central Qld. It has strong revenue and cost risk mitigants, CPI-linked base revenues boosted by incremental revenues from commissioned sustaining capex projects, very high EBITDA margins, and an investment grade credit profile. Investors comfortable with the coal-related exposure also benefit from the ESG discount imputed into the stock price.

      
DBI coverage report
      

Ventia Services Group (VNT)

Ventia Services Group (ASX: VNT) delivers essential services predominantly to government (c.75% of revenue), with an average contract tenure of c.5-7 years and direct inflation passthrough (95% of revenue) in most contracts. The industry grows at 6-7% pa, with VNT growing 7-10% through industry growth and contract expansion, whilst margins should remain stable. The stock continues to deliver a strong dividend yield, which we expect to continue growing at mid-single digits, whilst trading on an undemanding low double-digit PER.

      
VNT coverage report
      

Eagers Automotive (APE)

Eagers Automotive Limited (ASX: APE) is the leading automotive retail group in Australia and New Zealand, operating for over 100 years and representing a diverse portfolio of OEM (original equipment manufacturer) brands. While current industry dynamics in the auto sector (margin pressure; cost of living impacts) are expected to persist in the near-term, we view the scale operators (such as APE) as best placed to navigate this challenging dynamic. Longer-term, we are positive on APE’s various strategic initiatives and expect it can continue to scale; and sustain a structurally higher return on sales through the cycle.

      
APE research report
      

GQG Partners (GQG)

GQG Partners (ASX: GQG) is global asset management boutique, managing ~US$150bn in funds across four primary equity strategies. We like GQG given its highly effective distribution, scalable strategies, and strong long-term investment performance. We view the earnings tailwind from strong funds under management growth (a combination of investment performance and net fund inflows) will continue and we think GQG will continue to re-rate along with this to a higher earnings multiple in time.

      
GQG research report
      

HomeCo Daily Needs REIT (HDN)

HomeCo Daily Needs REIT (ASX: HDN) has a +$4.5bn real estate portfolio focused on daily needs retail (Large Format Retail; Neighbourhood; and Health Services) across +50 properties with the top five tenants being Woolworths, Coles, JB Hi-Fi, Bunnings and Spotlight. Most of leases are fixed. The portfolio has resilient cashflows, with the majority of tenants being national. Sites are in strategic locations with strong population growth. HDN offers an attractive distribution yield, with a +$600m development pipeline providing further growth.

      
HDN research report
      

IPH Limited (IPH)

IPH Limited (ASX: IPH) is a prominent IP services group with market leading shares in Australia, Singapore and Canada. A defensive business, IPH has strong cash flow generation (with high conversion to EBITDA) and a long-track record of paying dividends to shareholders. We like IPH and consider the return to organic growth (albeit subdued) as a key near-term catalyst for the group. Longer-term, we expect IPH to continue to prosecute its consolidation and network expansion strategy offshore.

      
IPH research report
      

Suncorp (SUN)

Suncorp (ASX: SUN) is well positioned to benefit from continued strong price increases going through the home and motor insurance market in Australia, we expect these price increases to be supportive of SUN’s margins expanding further over the next couple of years. Additionally SUN’s recent divestment of its bank was done at an excellent price and will allow the company to focus completely on its strongest business, general insurance, where it is a market leader.  Finally, post the bank sale, SUN now has >A$4bn of excess capital to return to shareholders, which will occur most likely via the way of a share consolidation and a small special dividend.

      
SUN research report
      

Super Retail Group (SUL)

Super Retail Group (ASX: SUL) is a large discretionary retailer comprising four well-known brands which span several categories, including: Supercheap Auto; rebel Sport; Boating, Camping and Fishing (BCF), and Macpac. We like SUL given its market leading scale (>740 stores), deep data capabilities, strong loyalty base and diversified portfolio of brands. SUL has a very strong net cash balance sheet, and we expect it is positioned for further capital management initiatives in the near-term (i.e. potential special dividends).

      
SUL research report
      

Woodside Energy (WDS)

Woodside Energy (ASX: WDS) is the largest ASX-listed oil and gas producer, and in the top 10 globally. While its share price has come under pressure, Woodside’s fundamentals have benefited from resilient oil/LNG prices, steady group production, progress on delivering its key growth projects, a robust level of profitability, and clear focus on its dividend profile. Woodside’s dividend payout ratio has averaged 80% of earnings for the last +5 years, which is impressive given the last 2 years have been a capex-heavy phase as its progressed construction of the Scarborough, Pluto Train 2, and Sangomar projects. With gearing remaining low and cash flow set to grow post the current investment phase, we see Woodside as likely to remain an attractive yield play.

      
WDS research report
      

Morgans clients receive exclusive insights such as access to the latest stock and sector coverage featured in the Month Ahead. Contact us today to begin your journey with Morgans.

      
Contact Us
      
Read more